Beatrix Stelte-ludwig

7 Patents

• US121448652024

  Antibody Drug Conjugates with Enzymatically Cleavable Groups

  BAYER PHARMA AKTIENGESELLSCHAFT

  0 cites
• US120654972024

  Methods of Treatment Using CCR8 Antibodies

  Bayer Aktiengesellschaft

  0 cites
• US120594722024

  Prodrugs of Cytotoxic Active Agents Having Enzymatically Cleavable Groups

  BAYER PHARMA AKTIENGESELLSCHAFT

  0 cites
• US118064042023

  Site Specific Homogeneous with KSP Inhibitors

  BAYER PHARMA AKTIENGESELLSCHAFT

  0 cites
• US116857142023

  Prodrugs of Cytotoxic Active Agents Having Enzymatically Cleavable Groups

  BAYER PHARMA AKTIENGESELLSCHAFT

  0 cites
• US116603512023

  Antibody Drug Conjugates (adcs) Having Enzymatically Cleavable Groups

  BAYER PHARMA AKTIENGESELLSCHAFT

  0 cites
• US116434692023

  Specific Antibody-drug-conjugates (adcs) with KSP Inhibitors and Anti-cd123-antibodies

  BAYER PHARMA AKTIENGESELLSCHAFT

  0 cites